Abstract
Septo-optic dysplasia (SOD) is a heterogeneous brain midline anomaly associated with ophthalmological, endocrinological, and/or neurodevelopmental symptoms. The clinical phenotype correlates with abnormal brain magnetic resonance imaging (MRI) findings. However, variations of the septum pellucidum (SP) appearance and their clinical impact have not been studied in depth. Sixty-eight patients with optic nerve hypoplasia (ONH) were investigated for the presence of associated SP anomalies and correlations between clinical findings and their MRI abnormalities established. Thirty patients had either complete (n = 22) or partial (n = 8) absence of the SP. Pituitary hormone deficiencies were present in 64% or 25% of the cases, respectively. Neurological symptoms did not occur in patients with SP remnants or unilateral ONH. Hippocampus abnormalities (43%) that have not been described before in SOD and falx abnormalities (17%) correlated significantly with neurological symptoms and developmental delay (p < 0.05 and p < 0.01, respectively). Maternal age at birth was low (21.2 years) and drug abuse during pregnancy was reported in 27% of the patients. Twelve patients with pituitary anomaly and ONH but normal SP showed similar clinical and MRI features, and were classified as SOD-like. The remaining 26 patients were not assigned to SOD. We conclude that unilateral ONH and SP remnants are associated with a milder SOD phenotype. Hippocampus abnormalities and falx abnormalities seem to constitute important features of severe clinical disease, irrespective of SP appearance. Our anamnestic data support the hypothesis of vascular disruption during embryogenesis.
Similar content being viewed by others
Abbreviations
- bONH:
-
Bilateral optic nerve hypoplasia
- CC:
-
Corpus callosum
- MPHD:
-
Multiple pituitary hormone deficiency
- ONH:
-
Optic nerve hypoplasia
- SOD:
-
Septo-optic dysplasia
- SP:
-
Septum pellucidum
- uONH:
-
Unilateral optic nerve hypoplasia
References
Argyropoulou M, Perignon F, Brunelle F, Brauner R, Rappaport R (1991) Height of normal pituitary gland as a function of age evaluated by magnetic resonance imaging in children. Pediatr Radiol 21:247–249
Arslanian SA, Rothfus WE, Foley TP Jr, Becker DJ (1984) Hormonal, metabolic, and neuroradiologic abnormalities associated with septo-optic dysplasia. Acta Endocrinol (Copenh) 107:282–288
Baker LL, Barkovich AJ (1992) The large temporal horn: MR analysis in developmental brain anomalies versus hydrocephalus. Am J Neuroradiol 13:115–122
Barkovich AJ, Fram EK, Norman D (1989) Septo-optic dysplasia: MR imaging. Radiology 171:189–192
Birkebaek NH, Patel L, Wright NB, Grigg JR, Sinha S, Hall CM, Price DA, Lloyd IC, Clayton PE (2003) Endocrine status in patients with optic nerve hypoplasia: relationship to midline central nervous system abnormalities and appearance of the hypothalamic-pituitary axis on magnetic resonance imaging. J Clin Endocrinol Metab 88:5281–5286
Brodsky MC, Glasier CM (1993) Optic nerve hypoplasia. Clinical significance of associated central nervous system abnormalities on magnetic resonance imaging. Arch Ophthalmol 111:66–74
Brodsky MC, Conte FA, Taylor D, Hoyt CS, Mrak RE (1997) Sudden death in septo-optic dysplasia. Report of 5 cases. Arch Ophthalmol 115:66–70
Cameron FJ, Khadilkar VV, Stanhope R (1999) Pituitary dysfunction, morbidity and mortality with congenital midline malformation of the cerebrum. Eur J Pediatr 158:97–102
Chen S, Léger J, Garel C, Hassan M, Czernichow P (1999) Growth hormone deficiency with ectopic neurohypophysis: anatomical variations and relationship between the visibility of the pituitary stalk asserted by magnetic resonance imaging and anterior pituitary function. J Clin Endocrinol Metab 84:2408–2413
Dattani MT, Martinez-Barbera JP, Thomas PQ, Brickman JM, Gupta R, Mårtensson IL, Toresson H, Fox M, Wales JKH, Hindmarsh PC, Krauss S, Beddington RSP, Robinson ICAF (1998) Mutations in the homeobox gene HESX1/Hesx1 associated with septo-optic dysplasia in human and mouse. Nat Genet 19:125–133
de Morsier G (1956) Etudes sur les dystrophies cranioencephaliques. III. Agénésie du septum lucidum pellucidum avec malformation du tractus optique: la dysplasie septo-optique. Schweiz Arch Neurol Psychiatr 77:267–292
Dominguez R, Aguirre Vila-Coro A, Slopis JM, Bohan TP (1991) Brain and ocular abnormalities in infants with in utero exposure to cocaine and other street drugs. Am J Dis Child 145:688–695
Hoyt WF, Kaplan SL, Grumbach MM, Glaser JS (1970) Septo-optic dysplasia and pituitary dwarfism. Lancet 1:893–894
Izenberg N, Rosenblum M, Parks JS (1984) The endocrine spectrum of septo-optic dysplasia. Clin Pediatr (Phila) 23:632–636
Kier EL, Kim JH, Fulbright RK, Bronen RA (1997) Embryology of the human fetal hippocampus: MR imaging, anatomy, and histology. Am J Neuroradiol 18:525–532
Lubinsky MS (1997) Association of prenatal vascular disruptions with decreased maternal age. Am J Med Genet 69:237–239
Lubinsky MS (1997) Hypothesis: septo-optic dysplasia is a vascular disruption sequence. Am J Med Genet 69:235–236
Margalith D, Jan JE, McCormick AQ, Tze WJ, Lapointe J (1984) Clinical spectrum of congenital optic nerve hypoplasia: review of 51 patients. Dev Med Child Neurol 26:311–322
Murray PG, Paterson WF, Donaldson MD (2005) Maternal age in patients with septo-optic dysplasia. J Pediatr Endocrinol Metab 18:471–476
Prayer D, Kasprian G, Krampl E, Ulm B, Witzani L, Prayer L, Brugger PC (2006) MRI of normal fetal brain development. Eur J Radiol 57:199–216
Rainbow LA, Rees SA, Shaikh MG, Shaw NJ, Cole T, Barrett TG, Kirk JM (2005) Mutation analysis of POUF-1, PROP-1 and HESX-1 show low frequency of mutations in children with sporadic forms of combined pituitary hormone deficiency and septo-optic dysplasia. Clin Endocrinol (Oxf) 62:163–168
Riedl SW, Mullner-Eidenböck A, Prayer D, Bernert G, Frisch H (2002) Auxological, ophthalmological, neurological and MRI findings in 25 Austrian patients with septo-optic dysplasia (SOD). Preliminary data. Horm Res 58(Suppl 3):16–19
Sato N, Hatakeyama S, Shimizu N, Hikima A, Aoki J, Endo K (2001) MR evaluation of the hippocampus in patients with congenital malformations of the brain. Am J Neuroradiol 22:389–393
Siatkowski RM, Sanchez JC, Andrade R, Alvarez A (1997) The clinical, neuroradiographic, and endocrinologic profile of patients with bilateral optic nerve hypoplasia. Ophthalmology 104:493–496
Sorkin JA, Davis PC, Meacham LR, Parks JS, Drack AV, Lambert SR (1996) Optic nerve hypoplasia: absence of posterior pituitary bright signal on magnetic resonance imaging correlates with diabetes insipidus. Am J Ophthalmol 122:717–723
Stanhope R, Preece MA, Brook CG (1984) Hypoplastic optic nerves and pituitary dysfunction. A spectrum of anatomical and endocrine abnormalities. Arch Dis Child 59:111–114
Thomas PQ, Dattani MT, Brickman JM, McNay D, Warne G, Zacharin M, Cameron F, Hurst J, Woods K, Dunger D, Stanhope R, Forrest S, Robinson ICAF, Beddington RSP (2001) Heterozygous HESX1 mutations associated with isolated congenital pituitary hypoplasia and septo-optic dysplasia. Hum Mol Genet 10:39–45
Traggiai C, Stanhope R (2002) Endocrinopathies associated with midline cerebral and cranial malformations. J Pediatr 140:252–255
Sponsors/acknowledgments
The study was a collaboration project of the Middle European Society for Paediatric Endocrinology (MESPE) and is supported, in part, by a grant from the Serono Company. The authors’ work was independent of the sponsors.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Riedl, S., Vosahlo, J., Battelino, T. et al. Refining clinical phenotypes in septo-optic dysplasia based on MRI findings. Eur J Pediatr 167, 1269–1276 (2008). https://doi.org/10.1007/s00431-007-0666-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00431-007-0666-x